Abstract
Background: An improved understanding of the genetic determinants of Parkinson's disease (PD) in underrepresented populations, and better characterization of genotype-phenotype correlations in monogenic PD, are needed. Scarce literature exists regarding the genetic aetiology of PD in Malays, who comprise 200 million individuals in South-East Asia. Phenotypic data regarding PARK-PINK1 are also limited. Methods: A multi-ethnic cohort of PD patients from Malaysia (n = 499, including 185 Malays) were tested using a next-generation sequencing-based PD gene panel. The prevalence and clinico-radiological features of patients with the PINK1 p. Leu347Pro mutation are described. This mutation has previously only been reported in people of Filipino or Chamorro (native Guamanian) ancestry. Results: Homozygous p. Leu347Pro mutations were found in five unrelated Malay patients, yielding a prevalence of 6.9% among Malays with PD onset ≤50 years (2.7% of the Malay group overall). This variant was not detected in the homozygous state in 300 Malay controls, but two were heterozygous carriers (0.67%) indicating a relatively high population frequency in keeping with the high frequency of PARK-PINK1 among Malay patients. Interesting clinical features were observed, e.g., differences in the age at PD onset and clinical progression, despite having the same point mutations. Previously unreported brain MRI abnormalities involving the corticospinal tract and hypothalamus, and “loss of the swallow tail” sign, were documented. Conclusions: This report contributes to the very limited literature on PD genetics in the Malay population, and more broadly to the epidemiological, phenotypic and neuroimaging characterization of PARK-PINK1. It also further supports the pathogenicity of the p. Leu347Pro variant.
| Original language | English |
|---|---|
| Journal | Parkinsonism and Related Disorders |
| Volume | 79 |
| Pages (from-to) | 34-39 |
| Number of pages | 6 |
| ISSN | 1353-8020 |
| DOIs | |
| Publication status | Published - 10.2020 |
Funding
AHT and SYL are supported by the University of Malaya Parkinson's Disease and Movement Disorder Research Program (PV035-2017). KL and CK are supported by the DFG (FOR2488). AAA is supported by a grant from the Ministry of Education Malaysia (FRGS/1/2018/SKK08/ UM /02/3). The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SYL, KL and CK have received honoraria from the Global Parkinson's Genetics Project (GP2) funded by the Michael J. Fox Foundation (MJFF) and the Aligning Science Across Parkinson's (ASAP) initiative. PB is an employee, and AR the founder and CEO, of Centogene AG. The other authors (AHT, YWT, JLL, AAA, NR, YTC, ASM, KA, ZAA, and SDP) have no conflict of interest.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 5 Gender Equality
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Research Area: Medical Genetics
Fingerprint
Dive into the research topics of 'PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver